HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Albrecht Günther Selected Research
Albrecht Günther Research Topics
Disease
10
Thrombocytopenia (Thrombopenia)
12/2023 - 11/2021
7
Stroke (Strokes)
01/2020 - 05/2005
6
Infarction (Infarctions)
02/2024 - 07/2004
6
Intracranial Sinus Thrombosis (Sinus Thrombosis)
12/2023 - 11/2021
5
Hematoma
01/2020 - 02/2015
4
Hemorrhage
12/2023 - 01/2019
4
Venous Thrombosis (Deep-Vein Thrombosis)
10/2022 - 08/2014
4
COVID-19
01/2022 - 11/2021
4
Cerebral Hemorrhage
01/2020 - 02/2015
4
Sepsis (Septicemia)
01/2019 - 08/2010
3
Brain Death (Brain Dead)
02/2024 - 12/2023
3
Thrombosis (Thrombus)
07/2023 - 11/2021
3
Ischemic Stroke
12/2022 - 01/2020
3
Seizures (Absence Seizure)
04/2016 - 06/2013
3
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2014 - 07/2004
2
Intracranial Hemorrhages (Intracranial Hemorrhage)
10/2023 - 01/2020
2
Nervous System Diseases (Neurological Disorders)
01/2022 - 01/2022
2
Torticollis (Wryneck)
10/2021 - 01/2019
2
Autoimmune Diseases of the Nervous System
07/2020 - 08/2016
2
Pain (Aches)
01/2019 - 06/2016
2
Neoplasms (Cancer)
01/2019 - 08/2016
2
Brain Ischemia (Cerebral Ischemia)
10/2006 - 07/2004
2
Alzheimer Disease (Alzheimer's Disease)
03/2006 - 01/2003
2
Ischemia
12/2005 - 07/2004
1
Harlequin syndrome
02/2024
1
Drug-Related Side Effects and Adverse Reactions
01/2023
1
Critical Illness (Critically Ill)
01/2022
1
Endocarditis
01/2022
1
Neurologic Manifestations (Neurological Manifestations)
01/2022
1
Heart Arrest (Cardiac Arrest)
11/2021
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2021
1
Thrombocytopenia chromosome breakage
11/2021
1
Deafness (Deaf Mutism)
11/2020
1
Neurodegeneration with brain iron accumulation (NBIA)
11/2020
1
Deglutition Disorders (Dysphagia)
11/2020
1
Dystonia (Limb Dystonia)
11/2020
1
Encephalitis (Encephalitis, Rasmussen)
01/2020
1
Convalescence
01/2019
1
Meningitis
08/2018
1
Brain Diseases (Brain Disorder)
08/2016
1
Status Epilepticus (Complex Partial Status Epilepticus)
08/2016
1
Septic Shock (Toxic Shock Syndrome)
06/2016
1
Chronic Pain
06/2016
1
Multiple Sclerosis
01/2016
Drug/Important Bio-Agent (IBA)
9
Vaccines
IBA
12/2023 - 11/2021
4
Antibodies
IBA
01/2022 - 07/2004
3
Intravenous Immunoglobulins (IVIG)
FDA Link
12/2023 - 11/2021
3
Anticonvulsants (Antiepileptic Drugs)
IBA
04/2016 - 06/2013
3
Oxygen (Dioxygen)
IBA
10/2006 - 06/2005
3
Proteins (Proteins, Gene)
FDA Link
03/2006 - 07/2004
2
Ad26COVS1
IBA
01/2022 - 11/2021
2
Messenger RNA (mRNA)
IBA
01/2022 - 12/2005
2
COVID-19 Vaccines
IBA
01/2022 - 11/2021
2
ChAdOx1 nCoV-19
IBA
01/2022 - 11/2021
2
Heparin (Liquaemin)
FDA Link
Generic
01/2022 - 11/2021
2
Botulinum Toxins (Botulinum Toxin)
IBA
10/2021 - 01/2019
2
Tissue Plasminogen Activator (Alteplase)
FDA Link
01/2020 - 05/2015
2
Anticoagulants
IBA
01/2019 - 02/2015
2
Anti-Bacterial Agents (Antibiotics)
IBA
08/2018 - 01/2014
2
Peptides (Polypeptides)
IBA
03/2006 - 01/2003
2
Enzymes
IBA
03/2006 - 01/2003
2
Amyloid beta-Peptides
IBA
03/2006 - 01/2003
2
Adenosine Triphosphate (ATP)
IBA
12/2005 - 07/2004
2
Purinergic P2X7 Receptors
IBA
12/2005 - 07/2004
1
Technetium Tc 99m Exametazime (Ceretec)
FDA Link
01/2024
1
mesoglycan
IBA
01/2022
1
Immunoglobulin G (IgG)
IBA
01/2022
1
Cytokines
IBA
01/2022
1
mRNA Vaccines
IBA
01/2022
1
Phosphopyruvate Hydratase (Enolase)
IBA
11/2021
1
Type A Botulinum Toxins (Botox)
FDA Link
10/2021
1
Iron
IBA
11/2020
1
Rituximab (Mabthera)
FDA Link
07/2020
1
Surface Antigens (Surface Antigen)
IBA
07/2020
1
Proteasome Inhibitors
IBA
07/2020
1
Autoantibodies
IBA
07/2020
1
Bortezomib (Velcade)
FDA Link
07/2020
1
idarucizumab
IBA
01/2020
1
Dabigatran
FDA Link
01/2020
1
Vitamin K
FDA Link
01/2019
1
N(4)-oleylcytosine arabinoside
IBA
01/2019
1
Antigens
IBA
08/2016
1
Membrane Proteins (Integral Membrane Proteins)
IBA
08/2016
1
Steroids
IBA
01/2016
1
Tryptophan (L-Tryptophan)
FDA Link
01/2016
Therapy/Procedure
9
Therapeutics
12/2022 - 01/2012
5
Critical Care (Surgical Intensive Care)
12/2023 - 06/2016
3
Conservative Treatment
02/2024 - 01/2016
3
Secondary Prevention
04/2016 - 06/2013
2
Decompressive Craniectomy
10/2023 - 02/2014
2
Thrombolytic Therapy
04/2019 - 05/2015
1
Extracorporeal Membrane Oxygenation
02/2024
1
CT protocol
12/2021
1
Resuscitation
11/2021
1
Patient Transfer (Patient Dumping)
01/2020
1
Length of Stay
01/2020
1
Treatment Delay
04/2019
1
Artificial Respiration (Mechanical Ventilation)
01/2019
1
Tracheostomy
01/2019
1
Anticoagulation Reversal
02/2015